Product Information
CITALOPRAM HBR 20 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0284 per EA under NDC 00378623205. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
20 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378623205
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077042On Market Since
7/28/2008
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 20 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 11.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0284 per EA |
|---|---|
| All-time high | $0.0427 (Feb 12, 2014) |
| All-time low | $0.0244 (Nov 20, 2024) |
| 52-week high | $0.0314 |
| 52-week low | $0.0284 |
| Median price | $0.0302 |
| Average price | $0.0305 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 20 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0284 per EA (NDC 00378623205), effective Jun 24, 2026.
How has the price of CITALOPRAM HBR 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 20 MG TABLET has declined 11.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 20 MG TABLET?
Since Nov 28, 2013, the NADAC for CITALOPRAM HBR 20 MG TABLET has ranged from a low of $0.0244 (Nov 20, 2024) to a high of $0.0427 (Feb 12, 2014), with a median of $0.0302 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 20 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as CITALOPRAM HBR 20 MG TABLET, but none are currently priced below it.
Who manufactures CITALOPRAM HBR 20 MG TABLET?
CITALOPRAM HBR 20 MG TABLET (NDC 00378623205) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification